{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T02:25:27Z","timestamp":1784082327543,"version":"3.55.0"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002918","name":"Copenhagen University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002918","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005111","name":"Rigshospitalet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005111","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Low levels of LDL cholesterol may be associated with risk of infectious disease. We tested the hypothesis that low LDL cholesterol due to genetic variation in the LDLR, PCSK9, and HMGCR genes and a polygenic LDL cholesterol score is associated with risk of infectious diseases in the general population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Using observational and Mendelian randomization designs, we examined associations of low plasma LDL cholesterol with risk of bacterial and viral infections in 119 805 individuals from the Copenhagen General Population Study\/Copenhagen City Heart Study, 468 701 from the UK Biobank, and up to 376 773 from the FinnGen Research Project. Observationally, low LDL cholesterol concentrations were associated with risk of hospitalization for both bacterial and viral infections. In genetic analyses, a 1\u2005mmol\/L lower LDL cholesterol was associated with lower plasma PCSK9 {\u22120.55\u2005nmol\/L [95% confidence interval (CI): \u22121.06 to \u22120.05]; P = 0.03}, leucocyte count [\u22120.42 \u00d7 109\/L (\u22120.61 to \u22120.24); P &amp;lt; 0.001], and high-sensitivity C-reactive protein [\u22120.44\u2005mg\/L (\u22120.79 to \u22120.09); P = 0.014]. Using an LDLR, HMGCR, and PCSK9 score, a 1\u2005mmol\/L lower LDL cholesterol was associated with risk ratios of 0.91 (95% CI: 0.86\u20130.97; P = 0.002) for unspecified bacterial infection, of 0.92 (0.87\u20130.97; P = 0.004) for diarrhoeal disease, and of 1.15 (1.03\u20131.29; P = 0.012) for unspecified viral infections and 1.64 (1.13\u20132.39; P = 0.009) for HIV\/AIDS. Using a polygenic LDL cholesterol score largely showed similar results and in addition a lower risk of 0.85 (0.76\u20130.96; P = 0.006) for bacterial pneumonia and 0.91 (0.82\u20130.99; P = 0.035) for sepsis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Genetically low LDL cholesterol concentrations were associated with lower concentration of markers of inflammation; lower risk of hospitalization for unspecified bacterial infections, infectious diarrhoeal diseases, bacterial pneumonia, and sepsis; and higher risk of viral infections and HIV\/AIDS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjopen\/oeaf009","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T07:21:39Z","timestamp":1738308099000},"source":"Crossref","is-referenced-by-count":4,"title":["Low LDL cholesterol and risk of bacterial and viral infections: observational and Mendelian randomization studies"],"prefix":"10.1093","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1701-595X","authenticated-orcid":false,"given":"Marianne","family":"Benn","sequence":"first","affiliation":[{"name":"Department of Clinical Biochemistry, Copenhagen University Hospital\u2014Rigshospitalet , Blegdamsvej 9, DK-2100 Copenhagen ,","place":["Denmark"]},{"name":"The Copenhagen General Population Study, Copenhagen University Hospital\u2014Herlev and Gentofte , Borgmester Ib Juuls vej 1, DK-2730 Herlev ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , Blegdamsvej 3, DK-2200 Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3024-2847","authenticated-orcid":false,"given":"Frida","family":"Emanuelsson","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Copenhagen University Hospital\u2014Rigshospitalet , Blegdamsvej 9, DK-2100 Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Tybj\u00e6rg-Hansen","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Copenhagen University Hospital\u2014Rigshospitalet , Blegdamsvej 9, DK-2100 Copenhagen ,","place":["Denmark"]},{"name":"The Copenhagen General Population Study, Copenhagen University Hospital\u2014Herlev and Gentofte , Borgmester Ib Juuls vej 1, DK-2730 Herlev ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , Blegdamsvej 3, DK-2200 Copenhagen ,","place":["Denmark"]},{"name":"The Copenhagen City Heart Study, Copenhagen University Hospital\u2014Bispebjerg and Frederiksberg , Bispebjerg Bakke 23, DK-2400 Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1954-7220","authenticated-orcid":false,"given":"B\u00f8rge G","family":"Nordestgaard","sequence":"additional","affiliation":[{"name":"The Copenhagen General Population Study, Copenhagen University Hospital\u2014Herlev and Gentofte , Borgmester Ib Juuls vej 1, DK-2730 Herlev ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , Blegdamsvej 3, DK-2200 Copenhagen ,","place":["Denmark"]},{"name":"The Copenhagen City Heart Study, Copenhagen University Hospital\u2014Bispebjerg and Frederiksberg , Bispebjerg Bakke 23, DK-2400 Copenhagen ,","place":["Denmark"]},{"name":"Department of Clinical Biochemistry, Copenhagen University Hospital\u2014Herlev and Gentofte , Borgmester Ib Juuls vej 1, DK-2730 Herlev ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"key":"2026061311575666300_oeaf009-B1","doi-asserted-by":"crossref","first-page":"258ra143","DOI":"10.1126\/scitranslmed.3008782","article-title":"PCSK9 is a critical regulator of the innate immune response and septic shock outcome","volume":"6","author":"Walley","year":"2014","journal-title":"Sci Transl Med"},{"key":"2026061311575666300_oeaf009-B2","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1164\/rccm.201505-0876CI","article-title":"The central role of proprotein convertase subtilisin\/kexin type 9 in septic pathogen lipid transport and clearance","volume":"192","author":"Walley","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2026061311575666300_oeaf009-B3","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1128\/CMR.16.3.379-414.2003","article-title":"Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock","volume":"16","author":"Van Amersfoort","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"2026061311575666300_oeaf009-B4","doi-asserted-by":"crossref","first-page":"12766","DOI":"10.1073\/pnas.96.22.12766","article-title":"Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor","volume":"96","author":"Agnello","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026061311575666300_oeaf009-B5","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41586-021-03913-5","article-title":"Structural insights into hepatitis C virus receptor binding and entry","volume":"598","author":"Kumar","year":"2021","journal-title":"Nature"},{"key":"2026061311575666300_oeaf009-B6","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s11883-022-01057-z","article-title":"Expanding biology of PCSK9: roles in atherosclerosis and beyond","volume":"24","author":"Seidah","year":"2022","journal-title":"Curr Atheroscler Rep"},{"key":"2026061311575666300_oeaf009-B7","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMoa1806747","article-title":"Mendelian randomization study of ACLY and cardiovascular disease","volume":"380","author":"Ference","year":"2019","journal-title":"N Engl J Med"},{"key":"2026061311575666300_oeaf009-B8","first-page":"1192","article-title":"From genome-wide association studies to Mendelian randomization: novel opportunities for understanding cardiovascular disease causality, pathogenesis, prevention, and treatment","volume":"114","author":"Benn","year":"2018","journal-title":"Cardiovasc Res"},{"key":"2026061311575666300_oeaf009-B9","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/ije\/dyv108","article-title":"Mendelian randomization: where are we now and where are we going?","volume":"44","author":"Burgess","year":"2015","journal-title":"Int J Epidemiol"},{"key":"2026061311575666300_oeaf009-B10","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"key":"2026061311575666300_oeaf009-B11","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/ng.2797","article-title":"Discovery and refinement of loci associated with lipid levels","volume":"45","author":"Willer","year":"2013","journal-title":"Nat Genet"},{"key":"2026061311575666300_oeaf009-B12","doi-asserted-by":"crossref","first-page":"j1648","DOI":"10.1136\/bmj.j1648","article-title":"Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer's disease and Parkinson's disease: Mendelian randomisation study","volume":"357","author":"Benn","year":"2017","journal-title":"BMJ"},{"key":"2026061311575666300_oeaf009-B13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/ng.75","article-title":"Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans","volume":"40","author":"Kathiresan","year":"2008","journal-title":"Nat Genet"},{"key":"2026061311575666300_oeaf009-B14","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"2026061311575666300_oeaf009-B15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/1403494811401482","article-title":"The Danish National Patient Register","volume":"39","author":"Lynge","year":"2011","journal-title":"Scand J Public Health"},{"key":"2026061311575666300_oeaf009-B16","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00125-006-0570-3","article-title":"Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome","volume":"50","author":"Benfield","year":"2007","journal-title":"Diabetologia"},{"key":"2026061311575666300_oeaf009-B17","doi-asserted-by":"crossref","first-page":"e1002793","DOI":"10.1371\/journal.pgen.1002793","article-title":"The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits","volume":"8","author":"Voight","year":"2012","journal-title":"PLoS Genet"},{"key":"2026061311575666300_oeaf009-B18","doi-asserted-by":"crossref","first-page":"894","DOI":"10.2337\/dc19-1850","article-title":"Impact of glucose level on micro- and macrovascular disease in the general population: a Mendelian randomization study","volume":"43","author":"Emanuelsson","year":"2020","journal-title":"Diabetes Care"},{"key":"2026061311575666300_oeaf009-B19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-1-4612-1694-0_15","volume-title":"Selected Papers of Hirotugu Akaike","author":"Akaike","year":"1998"},{"key":"2026061311575666300_oeaf009-B20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1536867X0300300101","article-title":"Instrumental variables and GMM: estimation and testing","volume":"3","author":"Baum","year":"2003","journal-title":"Stata J"},{"key":"2026061311575666300_oeaf009-B21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/EDE.0000000000000559","article-title":"Sensitivity analyses for robust causal inference from Mendelian randomization analyses with multiple genetic variants","volume":"28","author":"Burgess","year":"2017","journal-title":"Epidemiology"},{"key":"2026061311575666300_oeaf009-B22","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2307\/1907619","article-title":"The estimation of economic relationships using instrumental variables","volume":"26","author":"Sargan","year":"1958","journal-title":"Econometrica"},{"key":"2026061311575666300_oeaf009-B23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng.2480","article-title":"Large-scale association analysis identifies new risk loci for coronary artery disease","volume":"45","author":"Consortium CAD","year":"2013","journal-title":"Nat Genet"},{"key":"2026061311575666300_oeaf009-B24","author":"Nichols","year":"2007","journal-title":"IVPOIS: Stata module to estimate an instrumental variables Poisson regression via GMM"},{"key":"2026061311575666300_oeaf009-B25","volume-title":"Firenze, Italy: Pubblicazioni del R Istituto Superiore di Scienze Economiche e Commerciali di Firenze","author":"Bonferroni","year":"1936"},{"key":"2026061311575666300_oeaf009-B26","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1016\/j.jacc.2010.02.044","article-title":"PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses","volume":"55","author":"Benn","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026061311575666300_oeaf009-B27","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1017\/S0950268898001435","article-title":"Cohort study of serum total cholesterol and in-hospital incidence of infectious diseases","volume":"121","author":"Iribarren","year":"1998","journal-title":"Epidemiol Infect"},{"key":"2026061311575666300_oeaf009-B28","doi-asserted-by":"crossref","first-page":"862999","DOI":"10.3389\/fcvm.2022.862999","article-title":"Association of lipid levels with COVID-19 infection, disease severity and mortality: a systematic review and meta-analysis","volume":"9","author":"Chidambaram","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2026061311575666300_oeaf009-B29","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1172\/JCI118556","article-title":"Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections","volume":"97","author":"Netea","year":"1996","journal-title":"J Clin Invest"},{"key":"2026061311575666300_oeaf009-B30","doi-asserted-by":"crossref","first-page":"5899","DOI":"10.1016\/S0021-9258(20)81980-2","article-title":"Binding and partial inactivation of Staphylococcus aureus alpha-toxin by human plasma low density lipoprotein","volume":"258","author":"Bhakdi","year":"1983","journal-title":"J Biol Chem"},{"key":"2026061311575666300_oeaf009-B31","doi-asserted-by":"crossref","first-page":"2687692","DOI":"10.1155\/2020\/2687692","article-title":"PCSK9: a potential therapeutic target for sepsis","volume":"2020","author":"Yuan","year":"2020","journal-title":"J Immunol Res"},{"key":"2026061311575666300_oeaf009-B32","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/SHK.0000000000000682","article-title":"Differential expression of PCSK9 modulates infection, inflammation, and coagulation in a murine model of sepsis","volume":"46","author":"Dwivedi","year":"2016","journal-title":"Shock"},{"key":"2026061311575666300_oeaf009-B33","first-page":"343","article-title":"Low serum LDL cholesterol levels and the risk of fever, sepsis, and malignancy","volume":"37","author":"Shor","year":"2007","journal-title":"Ann Clin Lab Sci"},{"key":"2026061311575666300_oeaf009-B34","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/CCM.0000000000000165","article-title":"Low preoperative cholesterol level is a risk factor of sepsis and poor clinical outcome in patients undergoing cardiac surgery with cardiopulmonary bypass","volume":"42","author":"Lagrost","year":"2014","journal-title":"Crit Care Med"},{"key":"2026061311575666300_oeaf009-B35","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jcrc.2015.01.001","article-title":"Decreased serum level of lipoprotein cholesterol is a poor prognostic factor for patients with severe community-acquired pneumonia that required intensive care unit admission","volume":"30","author":"Chien","year":"2015","journal-title":"J Crit Care"},{"key":"2026061311575666300_oeaf009-B36","doi-asserted-by":"crossref","first-page":"e187223","DOI":"10.1001\/jamanetworkopen.2018.7223","article-title":"Association between low-density lipoprotein cholesterol levels and risk for sepsis among patients admitted to the hospital with infection","volume":"2","author":"Feng","year":"2019","journal-title":"JAMA Netw Open"},{"key":"2026061311575666300_oeaf009-B37","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1194\/jlr.R300019-JLR200","article-title":"Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host","volume":"45","author":"Khovidhunkit","year":"2004","journal-title":"J Lipid Res"},{"key":"2026061311575666300_oeaf009-B38","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jacl.2017.12.007","article-title":"Associations of lipoproteins with cardiovascular and infection-related outcomes in patients receiving hemodialysis","volume":"12","author":"Kaysen","year":"2018","journal-title":"J Clin Lipidol"},{"key":"2026061311575666300_oeaf009-B39","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1194\/jlr.P084277","article-title":"Lipid levels are inversely associated with infectious and all-cause mortality: international MONDO study results","volume":"59","author":"Kaysen","year":"2018","journal-title":"J Lipid Res"},{"key":"2026061311575666300_oeaf009-B40","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1161\/ATVBAHA.119.313381","article-title":"Causal inference for genetically determined levels of high-density lipoprotein cholesterol and risk of infectious disease","volume":"40","author":"Trinder","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026061311575666300_oeaf009-B41","doi-asserted-by":"crossref","first-page":"d7281","DOI":"10.1136\/bmj.d7281","article-title":"Statins and prevention of infections: systematic review and meta-analysis of data from large randomised placebo controlled trials","volume":"343","author":"van den Hoek","year":"2011","journal-title":"BMJ"},{"key":"2026061311575666300_oeaf009-B42","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.amjcard.2016.08.072","article-title":"Safety of alirocumab (a PCSK9 monoclonal antibody) from 14 randomized trials","volume":"118","author":"Jones","year":"2016","journal-title":"Am J Cardiol"},{"key":"2026061311575666300_oeaf009-B43","doi-asserted-by":"crossref","first-page":"e14164","DOI":"10.1111\/eci.14164","article-title":"Effect of statins on sepsis and inflammatory factors: a Mendelian randomization study","volume":"54","author":"Zhang","year":"2024","journal-title":"Eur J Clin Invest"},{"key":"2026061311575666300_oeaf009-B44","doi-asserted-by":"crossref","first-page":"e36288","DOI":"10.1097\/MD.0000000000036288","article-title":"Causal relationships between plasma lipids and sepsis: a Mendelian randomization study","volume":"102","author":"Chen","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"2026061311575666300_oeaf009-B45","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1080\/22221751.2021.1941276","article-title":"Berbamine inhibits Japanese encephalitis virus (JEV) infection by compromising TPRMLs-mediated endolysosomal trafficking of low-density lipoprotein receptor (LDLR)","volume":"10","author":"Huang","year":"2021","journal-title":"Emerg Microbes Infect"},{"key":"2026061311575666300_oeaf009-B46","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1073\/pnas.91.5.1839","article-title":"Members of the low density lipoprotein receptor family mediate cell entry of a minor-group common cold virus","volume":"91","author":"Hofer","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026061311575666300_oeaf009-B47","doi-asserted-by":"crossref","first-page":"e1009722","DOI":"10.1371\/journal.ppat.1009722","article-title":"Human low-density lipoprotein receptor plays an important role in hepatitis B virus infection","volume":"17","author":"Li","year":"2021","journal-title":"PLoS Pathog"},{"key":"2026061311575666300_oeaf009-B48","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1002\/hep.24603","article-title":"Opening the door for hepatitis C virus infection in genetically humanized mice","volume":"54","author":"Zeisel","year":"2011","journal-title":"Hepatology"},{"key":"2026061311575666300_oeaf009-B49","doi-asserted-by":"crossref","first-page":"e0154498","DOI":"10.1371\/journal.pone.0154498","article-title":"Alirocumab, a therapeutic human antibody to PCSK9, does not affect CD81 levels or hepatitis C virus entry and replication into hepatocytes","volume":"11","author":"Ramanathan","year":"2016","journal-title":"PLoS One"},{"key":"2026061311575666300_oeaf009-B50","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.3389\/fimmu.2018.01140","article-title":"Tetraspanin assemblies in virus infection","volume":"9","author":"Florin","year":"2018","journal-title":"Front Immunol"},{"key":"2026061311575666300_oeaf009-B51","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/postgradmedj-2020-139172","article-title":"Statin use and clinical outcomes in patients with COVID-19: an updated systematic review and meta-analysis","volume":"98","author":"Pal","year":"2022","journal-title":"Postgrad Med J"},{"key":"2026061311575666300_oeaf009-B52","doi-asserted-by":"crossref","first-page":"586308","DOI":"10.3389\/fgene.2020.586308","article-title":"Causal inference for genetic obesity, cardiometabolic profile and COVID-19 susceptibility: a Mendelian randomization study","volume":"11","author":"Aung","year":"2020","journal-title":"Front Genet"},{"key":"2026061311575666300_oeaf009-B53","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1161\/ATVBAHA.121.316324","article-title":"Causal associations between blood lipids and COVID-19 risk: a two-sample Mendelian randomization study","volume":"41","author":"Zhang","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026061311575666300_oeaf009-B54","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2304146","article-title":"Pitavastatin to prevent cardiovascular disease in HIV infection","volume":"389","author":"Grinspoon","year":"2023","journal-title":"N Engl J Med"},{"key":"2026061311575666300_oeaf009-B55","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1016\/j.jacc.2020.03.025","article-title":"Evolocumab in HIV-infected patients with dyslipidemia: primary results of the randomized, double-blind BEIJERINCK study","volume":"75","author":"Boccara","year":"2020","journal-title":"J Am Coll Cardiol"}],"container-title":["European Heart Journal Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjopen\/advance-article-pdf\/doi\/10.1093\/ehjopen\/oeaf009\/61738559\/oeaf009.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjopen\/article-pdf\/5\/1\/oeaf009\/61738559\/oeaf009.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjopen\/article-pdf\/5\/1\/oeaf009\/61738559\/oeaf009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T16:09:36Z","timestamp":1781453376000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjopen\/article\/doi\/10.1093\/ehjopen\/oeaf009\/7997052"}},"subtitle":[],"editor":[{"given":"Susanna C","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,12,24]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12,24]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjopen\/oeaf009","relation":{},"ISSN":["2752-4191"],"issn-type":[{"value":"2752-4191","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1]]},"published":{"date-parts":[[2024,12,24]]},"article-number":"oeaf009"}}